Location History:
- Darmstadt, DE (1976 - 1982)
- Traisa, DE (1981 - 1992)
- Muhltal-Traisa, DE (1994)
- Muhltal, DE (1995)
Company Filing History:
Years Active: 1976-1995
Title: The Innovative Contributions of Hans-Jochen Schliep
Introduction
Hans-Jochen Schliep is a notable inventor based in Traisa, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address cardiovascular and asthmatic disorders. With a total of 16 patents to his name, Schliep's work has had a considerable impact on medical science.
Latest Patents
One of his latest patents involves thiadiazinones, which are compounds characterized by their phosphodiesterase-inhibiting action. These compounds are particularly suitable for combating cardiovascular and asthmatic disorders. The formula I ##STR1## represents the innovative structure of these thiadiazinones, showcasing Schliep's commitment to advancing therapeutic options in medicine.
Career Highlights
Hans-Jochen Schliep is currently associated with Merck Patent Gesellschaft mit beschränkter Haftung, where he continues to innovate and develop new pharmaceutical solutions. His extensive experience and expertise in the field have positioned him as a key figure in the research and development of effective medical treatments.
Collaborations
Throughout his career, Schliep has collaborated with esteemed colleagues, including Rochus Jonas and Hans J. Enenkel. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the pharmaceutical industry.
Conclusion
Hans-Jochen Schliep's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of treatments for critical health issues, showcasing the importance of innovation in medicine.